Foreign-born patients with hepatocellular carcinoma had higher survival rates than those born in the United States, according to data published in JNCI: Journal of the National Cancer Institute. Researchers observed the disparity in 5-year survival among foreign- vs. U.S.-born patients across the four major racial and ethnic groups.
Immigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in the U.S., according to new research from the USC Norris Comprehensive Cancer Center. Immigrants comprise a significant proportion of those diagnosed with hepatocellular carcinoma in the U.S. Research has shown that birthplace, also referred to as nativity, impacts incidence and risk factors for HCC, but little was known about its influence on survival after diagnosis. The new study, just published in the Journal of the National Cancer Institute, identified a previously unrecognized disparity in survival after a diagnosis of liver cancer across all major racial/ethnic groups, with immigrants having better survival compared to those born in the U.S.
Keck Medicine of USC study shows that the incidence rate of metastatic prostate cancer rose as much as 43% in men 75 and older and 41% in men 45-74 after routine prostate cancer screenings were no longer recommended